Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9AWX3
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 227 | 231 | PF00656 | 0.518 |
CLV_NRD_NRD_1 | 3 | 5 | PF00675 | 0.718 |
CLV_NRD_NRD_1 | 49 | 51 | PF00675 | 0.278 |
CLV_PCSK_FUR_1 | 50 | 54 | PF00082 | 0.283 |
CLV_PCSK_KEX2_1 | 52 | 54 | PF00082 | 0.587 |
CLV_PCSK_PC1ET2_1 | 52 | 54 | PF00082 | 0.587 |
CLV_PCSK_SKI1_1 | 127 | 131 | PF00082 | 0.477 |
CLV_PCSK_SKI1_1 | 192 | 196 | PF00082 | 0.490 |
CLV_PCSK_SKI1_1 | 44 | 48 | PF00082 | 0.454 |
DEG_MDM2_SWIB_1 | 56 | 64 | PF02201 | 0.451 |
DOC_MAPK_gen_1 | 4 | 12 | PF00069 | 0.505 |
DOC_MAPK_JIP1_4 | 19 | 25 | PF00069 | 0.535 |
DOC_MAPK_MEF2A_6 | 19 | 27 | PF00069 | 0.615 |
DOC_MAPK_MEF2A_6 | 205 | 212 | PF00069 | 0.514 |
DOC_PP1_RVXF_1 | 125 | 131 | PF00149 | 0.491 |
DOC_PP4_FxxP_1 | 232 | 235 | PF00568 | 0.509 |
DOC_USP7_MATH_1 | 159 | 163 | PF00917 | 0.616 |
DOC_USP7_MATH_1 | 3 | 7 | PF00917 | 0.677 |
DOC_USP7_MATH_1 | 8 | 12 | PF00917 | 0.665 |
DOC_USP7_MATH_1 | 80 | 84 | PF00917 | 0.668 |
DOC_USP7_UBL2_3 | 205 | 209 | PF12436 | 0.523 |
LIG_14-3-3_CanoR_1 | 190 | 195 | PF00244 | 0.529 |
LIG_14-3-3_CanoR_1 | 4 | 12 | PF00244 | 0.388 |
LIG_14-3-3_CanoR_1 | 50 | 60 | PF00244 | 0.496 |
LIG_AP2alpha_1 | 228 | 232 | PF02296 | 0.550 |
LIG_BRCT_BRCA1_1 | 218 | 222 | PF00533 | 0.428 |
LIG_EH_1 | 74 | 78 | PF12763 | 0.576 |
LIG_FHA_1 | 121 | 127 | PF00498 | 0.496 |
LIG_FHA_1 | 136 | 142 | PF00498 | 0.360 |
LIG_FHA_1 | 161 | 167 | PF00498 | 0.564 |
LIG_FHA_1 | 169 | 175 | PF00498 | 0.466 |
LIG_FHA_1 | 186 | 192 | PF00498 | 0.392 |
LIG_FHA_2 | 142 | 148 | PF00498 | 0.500 |
LIG_FHA_2 | 222 | 228 | PF00498 | 0.379 |
LIG_LIR_Apic_2 | 230 | 235 | PF02991 | 0.593 |
LIG_LIR_Gen_1 | 57 | 67 | PF02991 | 0.547 |
LIG_LIR_Gen_1 | 95 | 104 | PF02991 | 0.409 |
LIG_LIR_Nem_3 | 219 | 225 | PF02991 | 0.406 |
LIG_LIR_Nem_3 | 57 | 63 | PF02991 | 0.559 |
LIG_LIR_Nem_3 | 92 | 96 | PF02991 | 0.397 |
LIG_MYND_1 | 204 | 208 | PF01753 | 0.440 |
LIG_NRBOX | 42 | 48 | PF00104 | 0.287 |
LIG_Pex14_2 | 228 | 232 | PF04695 | 0.523 |
LIG_Pex14_2 | 56 | 60 | PF04695 | 0.525 |
LIG_SH2_GRB2like | 216 | 219 | PF00017 | 0.445 |
LIG_SH2_NCK_1 | 35 | 39 | PF00017 | 0.572 |
LIG_SH2_SRC | 216 | 219 | PF00017 | 0.451 |
LIG_SH2_STAT3 | 96 | 99 | PF00017 | 0.494 |
LIG_SH2_STAT5 | 107 | 110 | PF00017 | 0.350 |
LIG_SH2_STAT5 | 216 | 219 | PF00017 | 0.401 |
LIG_SH2_STAT5 | 96 | 99 | PF00017 | 0.405 |
LIG_SH3_3 | 14 | 20 | PF00018 | 0.584 |
LIG_SH3_3 | 198 | 204 | PF00018 | 0.507 |
LIG_SH3_3 | 98 | 104 | PF00018 | 0.452 |
LIG_SUMO_SIM_par_1 | 21 | 26 | PF11976 | 0.528 |
LIG_TRAF2_1 | 162 | 165 | PF00917 | 0.540 |
LIG_WW_3 | 1 | 5 | PF00397 | 0.736 |
MOD_CK1_1 | 193 | 199 | PF00069 | 0.537 |
MOD_CK1_1 | 221 | 227 | PF00069 | 0.543 |
MOD_CK1_1 | 81 | 87 | PF00069 | 0.546 |
MOD_CK2_1 | 154 | 160 | PF00069 | 0.600 |
MOD_CK2_1 | 173 | 179 | PF00069 | 0.414 |
MOD_CK2_1 | 221 | 227 | PF00069 | 0.389 |
MOD_CK2_1 | 8 | 14 | PF00069 | 0.663 |
MOD_Cter_Amidation | 48 | 51 | PF01082 | 0.393 |
MOD_GlcNHglycan | 157 | 160 | PF01048 | 0.617 |
MOD_GSK3_1 | 150 | 157 | PF00069 | 0.554 |
MOD_GSK3_1 | 168 | 175 | PF00069 | 0.435 |
MOD_GSK3_1 | 76 | 83 | PF00069 | 0.544 |
MOD_N-GLC_2 | 231 | 233 | PF02516 | 0.529 |
MOD_NEK2_1 | 120 | 125 | PF00069 | 0.505 |
MOD_NEK2_1 | 154 | 159 | PF00069 | 0.642 |
MOD_NEK2_1 | 23 | 28 | PF00069 | 0.593 |
MOD_PIKK_1 | 183 | 189 | PF00454 | 0.449 |
MOD_PIKK_1 | 78 | 84 | PF00454 | 0.600 |
MOD_PK_1 | 190 | 196 | PF00069 | 0.572 |
MOD_PKA_1 | 51 | 57 | PF00069 | 0.525 |
MOD_PKA_2 | 18 | 24 | PF00069 | 0.622 |
MOD_PKA_2 | 3 | 9 | PF00069 | 0.403 |
MOD_PKA_2 | 52 | 58 | PF00069 | 0.554 |
MOD_Plk_1 | 172 | 178 | PF00069 | 0.476 |
MOD_Plk_1 | 23 | 29 | PF00069 | 0.542 |
MOD_Plk_2-3 | 160 | 166 | PF00069 | 0.613 |
MOD_Plk_2-3 | 173 | 179 | PF00069 | 0.382 |
MOD_Plk_2-3 | 18 | 24 | PF00069 | 0.532 |
MOD_Plk_4 | 150 | 156 | PF00069 | 0.587 |
MOD_Plk_4 | 173 | 179 | PF00069 | 0.489 |
MOD_Plk_4 | 18 | 24 | PF00069 | 0.510 |
MOD_Plk_4 | 190 | 196 | PF00069 | 0.397 |
MOD_Plk_4 | 218 | 224 | PF00069 | 0.559 |
MOD_Plk_4 | 8 | 14 | PF00069 | 0.498 |
MOD_Plk_4 | 85 | 91 | PF00069 | 0.484 |
MOD_SUMO_rev_2 | 113 | 118 | PF00179 | 0.496 |
MOD_SUMO_rev_2 | 61 | 69 | PF00179 | 0.558 |
TRG_ER_diArg_1 | 41 | 44 | PF00400 | 0.454 |
TRG_NLS_MonoCore_2 | 49 | 54 | PF00514 | 0.560 |
TRG_NLS_MonoExtN_4 | 50 | 55 | PF00514 | 0.555 |
TRG_Pf-PMV_PEXEL_1 | 127 | 132 | PF00026 | 0.526 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IHY5 | Leptomonas seymouri | 54% | 100% |
A0A0S4J677 | Bodo saltans | 23% | 77% |
A0A0S4JEV4 | Bodo saltans | 23% | 77% |
A0A1X0NX29 | Trypanosomatidae | 32% | 96% |
A0A3S7WYF1 | Leishmania donovani | 89% | 100% |
A4HDL2 | Leishmania braziliensis | 80% | 100% |
A4I0W9 | Leishmania infantum | 89% | 100% |
C9ZWH8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 31% | 96% |
Q4QAK1 | Leishmania major | 91% | 100% |
V5BAW4 | Trypanosoma cruzi | 32% | 81% |